29 April 2017 Multi-modal spectroscopic imaging with synchrotron light to study mechanisms of brain disease
Author Affiliations +
Proceedings Volume 10340, International Conference on Biophotonics V; 1034002 (2017) https://doi.org/10.1117/12.2272365
Event: International Conference on Biophotonics V, 2017, Perth, Australia
Abstract
The international health care costs associated with Alzheimer’s disease (AD) and dementia have been predicted to reach $2 trillion USD by 2030. As such, there is urgent need to develop new treatments and diagnostic methods to stem an international health crisis. A major limitation to therapy and diagnostic development is the lack of complete understanding about the disease mechanisms. Spectroscopic methods at synchrotron light sources, such as FTIR, XRF, and XAS, offer a “multi-modal imaging platform” to reveal a wealth of important biochemical information in situ within ex vivo tissue sections, to increase our understanding of disease mechanisms.
© (2017) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Kelly L. Summers, Kelly L. Summers, Nicholas Fimognari, Nicholas Fimognari, Ashley Hollings, Ashley Hollings, Mitchell Kiernan, Mitchell Kiernan, Virginie Lam, Virginie Lam, Rebecca J. Tidy, Rebecca J. Tidy, Ryu Takechi, Ryu Takechi, Graham N. George, Graham N. George, Ingrid J. Pickering, Ingrid J. Pickering, John C. Mamo, John C. Mamo, Hugh H. Harris, Hugh H. Harris, Mark J. Hackett, Mark J. Hackett, } "Multi-modal spectroscopic imaging with synchrotron light to study mechanisms of brain disease", Proc. SPIE 10340, International Conference on Biophotonics V, 1034002 (29 April 2017); doi: 10.1117/12.2272365; https://doi.org/10.1117/12.2272365
PROCEEDINGS
1 PAGES


SHARE
Back to Top